Strides Pharma Science Ltd Board of Directors
Board of Directors at Strides Pharma Science Ltd
Director (Business Developmnt)
Non-Exec. & Independent Dir.
Executive Chairman & M.D.
Managing Director & Group CEO
Non-Exec. & Independent Dir.
Key Highlights
- Arun Kumar joins the board as Chairman & Non Executive Dir., in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Badree Komandur joins the board as Executive Director / WTD / Managing Director / CEO, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kausalya Santhanam joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Mukta Malik Arora joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Homi R Khusrokhan joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Strides Pharma Science Ltd
NSE: STAR
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 17 Apr 2026 | 1000.7 |
| 16 Apr 2026 | 993.9 |
| 15 Apr 2026 | 1002.25 |
| 13 Apr 2026 | 1001.7 |
| 10 Apr 2026 | 1000.65 |
| 09 Apr 2026 | 996.35 |
| 08 Apr 2026 | 967.1 |
| 07 Apr 2026 | 994.2 |
| 06 Apr 2026 | 981.5 |
| 02 Apr 2026 | 969.75 |
Company Fundamentals for Strides Pharma Science Ltd
Market Cap
9,223 Cr
EPS
59.8
P/E Ratio (TTM)
16.7
P/B Ratio (TTM)
3.3
Day’s High
1012.0
Day’s Low
993.9
DTE
0.7
ROE
14.4
52 Week High
1024.9
52 Week Low
616.45
ROCE
15.0
Market Price of Strides Pharma Science Ltd
1M
1Y
3Y
5Y
Strides Pharma Science Ltd News Hub
Strides Alathur successfully concludes USFDA inspection
Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab
Read more
19 Aug 24
Strides Pharma arm gets EIR from USFDA for Chennai facility
The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US
Read more
19 Aug 24
Strides Pharma hits 52-week high after dissolution of US unit
Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the
Read more
16 Aug 24
Strides Pharma Science to hold EGM
Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be
Read more
09 Aug 24
